OCT 19, 2021 8:00 AM PDT

Mild COVID Produces Better Than Expected Antibody Responses

WRITTEN BY: Tara Fernandez

Over millions of years, the immune system has evolved to shield us against disease-causing pathogens that we encounter early in life. When it comes to the coronavirus, immunologists previously believed that only those who recovered from severe infections developed immune protection. 

However, a growing body of research contradicts these earlier sentiments—even those who experienced mild bouts of COVID-19 produced sustained levels of antibodies against the virus.

University of Michigan researcher Charles Schuler led a team that tracked immune responses in recovering COVID patients. Of the 130 study participants, three were hospitalized with severe symptoms, while the rest experienced much milder infection symptoms such as headaches and a loss of smell.

The researchers measured the levels of antibodies against the virus’ spike protein and nucleocapsid at the three- and six-month mark after infection. In results reported in Microbiology Spectrum, 90 percent of the participants had strong antibody levels, suggesting natural immunity shielded against virus reinfection for at least six months.

Throughout the study, none of the participants with circulating neutralizing antibodies got reinfected, while 15 antibody-negative patients did. Interestingly, contrary to earlier hypotheses that the strength of COVID neutralizing antibodies wane over time, Schuler and team found that the patients’ antibodies remained as potent between the three- and six-month marks.

This study represents one of the first to provide evidence for longer-term immunity in those who experience mild COVID infections.

Schuler cautions that while these findings are encouraging for those who have fully recovered from COVID, this is not a reason to skip vaccinations in favor of acquiring natural immunity.

“Vaccination decreases infectiousness, the risk of hospitalization and deaths from COVID-19, without having the actual infection,” commented Schuler. “Achieving natural immunity by deferring vaccination in favor of infection is not worth going through the discomfort, risk to yourself and risk to others.”

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 26, 2021
Immunology
Sugar-Coating Organs Stops Them From Getting Rejected
AUG 26, 2021
Sugar-Coating Organs Stops Them From Getting Rejected
Once organ failure patients receive the gift of a transplant, they face a life-long threat of immune rejection. Their im ...
SEP 07, 2021
Health & Medicine
Vaccines- a Long History of Cost-Benefit Analysis
SEP 07, 2021
Vaccines- a Long History of Cost-Benefit Analysis
Vaccination and new treatments for diseases have remained topics of skepticism since their inception. When it came to an ...
OCT 04, 2021
Cancer
Predicting Progression-Free Survival in a Melanoma Study
OCT 04, 2021
Predicting Progression-Free Survival in a Melanoma Study
IsoPlexis’ Single-Cell Proteomics Predict Progression-Free Survival in Melanoma Study While advancements in oncolo ...
OCT 12, 2021
Drug Discovery & Development
Preventing future pandemics - Scientists developing broadly protective vaccines against coronaviruses
OCT 12, 2021
Preventing future pandemics - Scientists developing broadly protective vaccines against coronaviruses
Researchers at Japan’s Osaka University recently developed and tested a novel vaccine that may protect a ...
NOV 08, 2021
Cell & Molecular Biology
Understanding How Problems in Bone Marrow Transplants Arise
NOV 08, 2021
Understanding How Problems in Bone Marrow Transplants Arise
The hematopoietic system is how new blood cells are formed; hematopoietic stem cells in bone marrow generate new hematop ...
NOV 21, 2021
Microbiology
Rare Genetic Variant Can Make People Susceptible to Bird Flu H7N9
NOV 21, 2021
Rare Genetic Variant Can Make People Susceptible to Bird Flu H7N9
Zoonosis is a serious health concern, as the COVID-19 pandemic has shown. Viruses that infect one species can acquire ge ...
Loading Comments...